Skip to Main content Skip to Navigation
Journal articles

The Amaryllidaceae Alkaloid Haemanthamine Binds the Eukaryotic Ribosome to Repress Cancer Cell Growth

Abstract : Alkaloids isolated from the Amaryllidaceae plants have potential as therapeutics for treating human diseases. Haemanthamine has been studied as a novel anticancer agent due to its ability to overcome cancer cell resistance to apoptosis. Biochemical experiments have suggested that hemanthamine targets the ribosome. However, a structural characterization of its mechanism has been missing. Here we present the 3.1 Å resolution X-ray structure of haemanthamine bound to the Saccharomyces cerevisiae 80S ribosome. This structure reveals that haemanthamine targets the A-site cleft on the large ribosomal subunit rearranging rRNA to halt the elongation phase of translation. Furthermore, we provide evidence that haemanthamine and other Amaryllidaceae alkaloids also inhibit specifically ribosome biogenesis, triggering nucleolar stress response and leading to p53 stabilization in cancer cells. Together with a computer-aided interpretation of existing structure-activity relationships of Amaryllidaceae alkaloids congeners, we provide a rationale for designing molecules with enhanced potencies and reduced toxicities.
Document type :
Journal articles
Complete list of metadata

https://hal.archives-ouvertes.fr/hal-03661103
Contributor : Gulnara Yusupova Connect in order to contact the contributor
Submitted on : Friday, May 6, 2022 - 3:35:14 PM
Last modification on : Wednesday, May 11, 2022 - 3:05:12 AM

Links full text

Identifiers

Collections

Citation

Simone Pellegrino, Mélanie Meyer, Christiane Zorbas, Soumaya Bouchta, Kritika Saraf, et al.. The Amaryllidaceae Alkaloid Haemanthamine Binds the Eukaryotic Ribosome to Repress Cancer Cell Growth. Structure, Elsevier (Cell Press), 2018, 26 (3), pp.416-425.e4. ⟨10.1016/j.str.2018.01.009⟩. ⟨hal-03661103⟩

Share

Metrics

Record views

17